Clinical Trial Update: Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

View source ↗

Summary

A prospective, multicenter cohort study evaluating allogeneic versus autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Peripheral T Cell Lymphoma | Status: RECRUITING